DSGN - Financial Reports List - Design Therapeutics, Inc. - IntrinsicAlpha

Design Therapeutics, Inc. DSGN

Healthcare - Biotechnology - NASDAQ - US

$ 3.805

2.57 %

$ 216 M

Market Cap

-4.08

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	0.00%	-15.28%	-10.40%
Annual Report	FY	10-K	2024-12-31	0.00%	25.84%	20.22%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	17.42%	13.69%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	40.85%	33.43%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	34.43%	33.49%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	21.91%	22.02%
Annual Report	FY	10-K	2023-12-31	0.00%	-14.07%	-15.68%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	2.63%	1.93%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-38.85%	-44.48%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	-28.70%	-61.94%

1